Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YrdC N(6)-threonylcarbamoyltransferase domain containing pseudogene 3 (YRDCP3) is a **pseudogene** located on chromosome 21q22.2[4]. As a pseudogene, it is a non-functional genomic DNA sequence that resembles a functional gene (likely derived from the functional YRDC gene, which encodes threonylcarbamoyltransferase domain protein)[3][5]. There is no evidence that YRDCP3 encodes a protein or serves as a receptor, enzyme, transporter, or therapeutic target. It is not associated with any known biological function, disease process, or drug interaction, and is considered non-coding and non-functional based on all available data[3][5]. **Note:** - This entry specifically refers to the pseudogene "YRDCP3", not the protein-coding gene YRDC. If you intended the functional gene (YRDC, also called YrdC N(6)-threonylcarbamoyltransferase domain containing), its biological role, functions, and disease associations would differ markedly[6][7]. - Pseudogenes can sometimes have regulatory effects, but there is no evidence in the current literature that YRDCP3 plays such a role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YrdC N(6)-threonylcarbamoyltransferase domain containing pseudogene 3 (YRDCP3).